The global cell culture market size was estimated at USD 16.4 billion in 2014. Development of novel three-dimensional cell culture techniques and growing need for these techniques for biopharmaceutical development and vaccine production are expected to drive demand and growth in revenue.
Growing advancement of proteomic gene expression and consequent development of novel vaccine and biopharmaceuticals is anticipated to drive demand for newer 3D cell culturing techniques and cell cultures over the forecast period. Further increase in the number of cancer research projects and enhanced applications of gene therapies are also factors expected to drive the demand in this market over the forecast period.
Owing to the cost and investment involved in setting up cell culture technology infrastructure, the number of contract research and manufacturing is increasing. Increasing incidences of chronic diseases have led to increase in cell biology & cytological studies and associated research resulting in the growth for cell culture. The stem cell therapy research is at its peak in order to treat the cause of the disease supported by huge funding for the same.
The limited applicability of conventional pharmaceuticals and few numbers of players in the biotechnology industry has fueled the growth of cell culture technology. The market for these artificial organs is expected to grow at a significantly high growth rate in the near future, indicating an increasing demand and strong growth potential for the cell culture market.
Development of specialty growth media and culture techniques that ensure specificity and availability of high-end technology for scaling up cultures are important factors that are expected to drive growth in these market segments.
Based on consumables, the market is segmented into cell culture media, sera, and reagent. The highest growth among these segments is being observed in the media market. The cell culture market is driven by increasing vertical integration, growth of the biopharmaceutical industry owing to increasing demand and preference for alternative media.
Cell culture media forms the largest share by volume for any culture preparation. However, as compared to average market prices of sera and reagents, media is very lower-priced, and thus even though having a higher volume consumption accounts for a smaller share of the revenue. Growing demand for culturing in cytological research projects, it is expected that the segment will witness considerable demand over the forecast period.
Cell culture products are characterized by higher profit margins and technological advancements are key for the growth of these segments. The primary clients are research laboratories and cell culture application development companies. Major segments included are culture systems, incubators, centrifuges, cryostorage equipment, biosafety equipment, and pipetting instruments.
Cell culture systems account for the largest share of this market due to the introduction of technological advancements in operation and design of these systems for researchers and laboratories. The development of automated robotic liquid handling systems is expected to enhance culture capacity and maintenance of high levels of purity in a reproducible manner.
Biopharmaceuticals were observed to account for the largest share of revenue for 2014 in the applications of cell culture techniques. Due to the primary usage of mammalian cell cultures in the production of mammalian pharmaceuticals and the growing demand for non-conventional drugs developed as a result of bio-production of proteomically and genetically enhanced drugs, this segment is expected witness lucrative growth in demand over the forecast period.
With the advancement in technologies to develop and culture tissue from cells for use in grafting and techniques of personalized genomic and proteomic surgical therapies, growth in demand for these techniques is also expected to significantly drive demand for cell culturing over the forecast period.
North America forms the largest market for cell culture consumables and instruments. Development of animal-component free media and presence of novel automated cell culture systems reducing the lag times and enhancing the production capacity of entire projects are some factors expected to enhance the demand for cell culture techniques over the forecast period.
Asia Pacific is expected to grow at the fastest CAGR owing to increasing number of contract manufacturing and outsourcing of cell culture technology. The increasing demand for cell culture media and the rise in biopharmaceutical research has led to the rise of this industry.
Key participants of the cell culture market include Sigma-Aldrich Co., LLC, Sartorius, Thermo Fisher Scientific, Becton, Dickinson & Company, General Electric, Lonza, Corning, Merck, Promocell, and Eppendorf.
Many pharmaceutical companies are acquiring or merging with biotechnological companies in order to expand their product portfolios and strengthen their market position.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2022
Revenue in USD Million and CAGR from 2017 to 2022
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, UK, China, Japan, Brazil, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research has segmented the global cell culture market report on the basis of consumables, products, application, and region:
Consumable Outlook (Revenue, USD Million, 2012 - 2022)
Minimum Essential Media (MEM)
RPMI 1640 Media
F-10 Serum Free Media
Fetal Bovine Serum
Other Animals’ serum
Product Outlook (Revenue, USD Million, 2012 - 2022)
Application Outlook (Revenue, USD Million, 2012 - 2022)
Tissue Culture & Engineering
Regional Outlook (Revenue, USD Million, 2012 - 2022)
Middle East & Africa
b. According to the study by Grand View Research, the market size of global cell culture market is projected to reach USD 37.0 billion by 2022.
b. North America accounted for the largest cell culture market share in 2014.
b. Key participants include Sigma-Aldrich Co., LLC, Sartorius, Thermo Fisher Scientific, Becton, Dickinson & Company, General Electric, Lonza, Corning, Merck, Promocell, and Eppendorf.
b. Asia Pacific region is anticipated to grow during the forecast period owing to the presence of high unmet need for increasing production and development of vaccines, drugs, and new biologics.
b. The key players are involved in extensive R&D of 3D cell culture and full commercialization of the technologically advanced cell culture which offer higher accuracy of replication, greater purity and rapid growth.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.